Indici bursieri Piețe bursiere Simboluri Statistici

Simbol LLY
Eli Lilly & Co.

luni, 27 mai 2024, ora 09:56:16 EEST (UTC + 3)

Simbol LLY
Simbol LLY
Simbol eToro LLY
MarketWatch LLY
Finviz LLY
Yahoo Finance LLY
Google Finance LLY
TradingView LLY
Investing.com LLY
Denumire Eli Lilly & Co.
Website lilly.com
Piața NYSE
ISIN US5324571083
Sector Health Technology
Industrie Pharmaceuticals Major
Monedă USD
Preț 567,8100 USD
Capitalizare bursieră 539,020 mld. USD
P/E 104,81
Beta 0,5336
Dividend 0,80%
EPS 5,4176
Profit anual +55,54%
Dată actualizare 03.11.2023


Descriere
Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. The firm's products consist of Diabetes, Oncology, Immunology, Neuroscience, and Other therapies. The Diabetes products include Baqsimi, Basaglar, Humalog, Humulin, Jardiance, Lyumjev, Trajenta, and Trulicity. The Oncology products consist of Alimta, Cyramza, Erbitux, Retevmo, Tyvyt, and Verzenio. The Immunology products include Olumiant and Taltz. The Neuroscience products consist of Cymbalta, Emgality, Reyvow, and Zyprexa. The Other therapies include Bamlanivimab, Cialis, and Forteo. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.


Istoric cotații

Data P/E Beta Capitalizare Dividend EPS Profit anual Preț
15.11.2022 53,48 0,6469 338,320 1,10% 6,6583 +37,65% $356,06
05.12.2022 56,28 0,6419 356,090 1,05% 6,6583 +52,12% $374,76
14.02.2023 50,77 0,6287 332,940 1,16% 6,9023 +48,33% $346,74
14.07.2023 72,62 0,5168 426,660 0,97% 6,1893 +39,62% $449,46
03.11.2023 104,81 0,5336 539,020 0,80% 5,4176 +55,54% $567,81



Pagină vizualizată de 72 ori și generată în 0,038279 secunde.